R1 RCM Inc. is an American 'revenue cycle management' company servicing hospitals, health systems and physician groups across the United States.

In November 2024, TowerBrook Capital Partners and Clayton, Dubilier & Rice completed the purchase of R1, in a deal that valued the company at $8.9 billion.

[4][5] In July 2012, Accretive Health entered into a $2.5 million settlement with the Minnesota Attorney General following an investigation into the company's debt collection practices.

[9] In March 2014, as a result of missed financial restatements, Accretive Health was delisted from the New York Stock Exchange;[10] over-the-counter trading continued.

In March 2024, R1 RCM Inc. filed a notice of data breach with the Attorney General of Massachusetts after discovering that an unauthorized party was able to access confidential information belonging to certain consumers.